HeadlinesBriefing favicon HeadlinesBriefing

Private Equity 8 Hours

×
1 articles summarized · Last updated: LATEST

Last updated: September 9, 2026, 10:16 PM ET

Private Equity

Iron Path Capital’s VION Biosciences completed its acquisition of Prolytix, a provider of regulated bioanalytical and CMC services. The deal expands VION’s capabilities for biopharma and diagnostics clients, marking a strategic consolidation in specialty life-sciences services.